Author

Nili Ramu

Observed institutions: Hadassah Medical Center, Assaf Harofeh Medical Center

OpenAlex ID: A5110033612

Reversal of multidrug resistance by phenothiazines and structurally related compounds

1992 · Avner Ramu, Nili Ramu · Cancer Chemotherapy and Pharmacology · 113

The diagnostic and prognostic value of ProGRP in lung cancer.

2009 · Benjamin Nisman, Haim Biran, et al. · PubMed · 67

The isolation and purification of human peripheral blood monocytes in cell suspension

1980 · Abraham J. Treves, Dvora Yagoda, et al. · Journal of Immunological Methods · 63

Eosinophilic Granuloma of the Spine

1997 · Yizhar Floman, Elhanan Bar-On, et al. · Journal of Pediatric Orthopaedics B · 61

Circumvention of adriamycin resistance by dipyridamole analogues: A structure‐activity relationship study

1989 · Nili Ramu, Avner Ramu · International Journal of Cancer · 52

Reversal of multidrug resistance by bis(phenylalkyl)amines and structurally related compounds

1994 · Avner Ramu, Nili Ramu · Cancer Chemotherapy and Pharmacology · 26

Circumvention of multidrug-resistance in P388 cells is associated with a rise in the cellular content of phosphatidylcholine

1991 · Avner Ramu, Nili Ramu, et al. · Biochemical Pharmacology · 25

Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms

1999 · Ana Gafanovich, Nili Ramu, et al. · Cancer · 23

Reduced ouabain-sensitive potassium entry as a possible mechanism of multidrug-resistance in P388 cells

1991 · Avner Ramu, Nili Ramu, et al. · Biochemical Pharmacology · 10

Resistance to Lipophilic Cationic Compounds in Multidrug Resistant Leukemia Cells

1993 · Avner Ramu, Nili Ramu · Leukemia & lymphoma/Leukemia and lymphoma · 7

The cytotoxicity of T-2 toxin and related 12,13-epoxytrichothecenes to Adriamycin-sensitive and-resistant P388 leukemia cells

1989 · Avner Ramu, Boris Yagen, et al. · Cancer Chemotherapy and Pharmacology · 6

Expect the unexpected: peritoneal spread--late relapse presentation of breast cancer.

2008 · Daniela Katz, Tamar Peretz, et al. · PubMed · 2

P3-086: Initial safety results from expended access program (EAP) with erlotinib in non small cell lung cancer (NSCLC) in Israel

2007 · Maya Gottfried, Mark Levit, et al. · Journal of Thoracic Oncology

Works count: 13

Citation count: 455

H-index: 9

I10-index: 9